Glycosidase

Glycosidase inhibitors, enzymes and substrates are tools for studying how glycans are broken down. Glycosidases remove sugars from glycoproteins, glycolipids and polysaccharides and shape N-glycan processing in the endoplasmic reticulum and Golgi apparatus. Kifunensine, an alkaloid, was reported in 1990 to inhibit glycoprotein processing mannosidase I, so N-glycans stay in high-mannose form. Peptide-N-glycosidase F (PNGase F) releases intact N-linked glycans from glycoproteins, as described in 1985. OGT2115 inhibits heparanase, the endo-β-glucuronidase that cleaves heparan sulfate chains. M-31850 inhibits β-hexosaminidase, and PFB-FDGlu is a fluorogenic substrate for glucocerebrosidase (GCase). Enzymes that cleave glucose residues have their own neighboring category, Glucosidase.

3 Items

  • β-Glucocerebrosidase modulator 1
    Cat. No.
    A75066

    β-Glucocerebrosidase modulator 1

    β-Glucocerebrosidase modulator 1 is a potent allosteric modulator targeting β-Glucocerebrosidase, with an EC50 of 9.0 μM and a Kd of 0.050 μM. This compound enhances the enzymatic activity of β-Glucocerebrosidase, making it a valuable tool for studying Gaucher disease and related lipid metabolism disorders. Its modulation of enzymatic function assists in elucidating biological pathways and may aid in the development of therapeutic interventions.

    5 mg
    $1,090.00
    10 mg
    $1,680.00
    All 3 sizes
  • OMJ-4
    Cat. No.
    A75119

    OMJ-4

    OMJ-4 is a modulator of mutant alpha-mannosidase that enhances its catalytic function. This compound promotes structural changes in the enzyme, increasing both the compactness and flexibility of the active site, which facilitates substrate binding. By inducing greater substrate reactivity, OMJ-4 decreases the activation energy needed for the enzymatic reaction. This reagent is significant for research focused on alpha-mannosidosis and related metabolic disorders.

    Out of stock

    All 3 sizes
  • JZ-4109
    Cat. No.
    A75153

    JZ-4109

    JZ-4109 is a potent β-Glucocerebrosidase (GCase) modulator, exhibiting an IC50 of 8 nM against wild-type recombinant GCase. This compound binds to an allosteric site at the GCase dimer interface, promoting dimerization and stabilizing both wild-type and GCase N370S mutant variants. JZ-4109 enhances GCase protein abundance, making it a valuable tool for research into Parkinson's disease and related conditions.

    Out of stock

    All 3 sizes

3 Items

Added to your cart

View Cart Checkout

    Loading...